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The optimal design of stepped wedge
trials with equal allocation to
sequences and a comparison to other
trial designs
Jennifer AThompson1,2, Katherine Fielding1, James Hargreaves3 and
Andrew Copas2
Abstract
Background/Aims: We sought to optimise the design of stepped wedge trials with an equal allocation of clusters to
sequences and explored sample size comparisons with alternative trial designs.
Methods: We developed a new expression for the design effect for a stepped wedge trial, assuming that observations
are equally correlated within clusters and an equal number of observations in each period between sequences switching
to the intervention. We minimised the design effect with respect to (1) the fraction of observations before the first and
after the final sequence switches (the periods with all clusters in the control or intervention condition, respectively) and
(2) the number of sequences. We compared the design effect of this optimised stepped wedge trial to the design effects
of a parallel cluster-randomised trial, a cluster-randomised trial with baseline observations, and a hybrid trial design (a
mixture of cluster-randomised trial and stepped wedge trial) with the same total cluster size for all designs.
Results:We found that a stepped wedge trial with an equal allocation to sequences is optimised by obtaining all observa-
tions after the first sequence switches and before the final sequence switches to the intervention; this means that the first
sequence remains in the control condition and the last sequence remains in the intervention condition for the duration of
the trial. With this design, the optimal number of sequences is 1=(1 ﬃﬃﬃRp ), where R= rm=(1+ r(m 1)) is the
cluster-mean correlation, r is the intracluster correlation coefficient, and m is the total cluster size. The optimal number
of sequences is small when the intracluster correlation coefficient and cluster size are small and large when the intraclus-
ter correlation coefficient or cluster size is large. A cluster-randomised trial remains more efficient than the optimised
stepped wedge trial when the intracluster correlation coefficient or cluster size is small. A cluster-randomised trial with
baseline observations always requires a larger sample size than the optimised stepped wedge trial. The hybrid design can
always give an equally or more efficient design, but will be at most 5% more efficient. We provide a strategy for selecting
a design if the optimal number of sequences is unfeasible. For a non-optimal number of sequences, the sample size may be
reduced by allowing a proportion of observations before the first or after the final sequence has switched.
Conclusion: The standard stepped wedge trial is inefficient. To reduce sample sizes when a hybrid design is unfeasible,
stepped wedge trial designs should have no observations before the first sequence switches or after the final sequence
switches.
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Introduction
Stepped wedge trials (SWTs) are growing in popularity,
but modification of the design to minimise their sample
size have not been fully explored.
In an SWT, clusters are randomised into allocation
sequences. Sequences consist of a different number of
periods in the control condition, followed by the
remaining periods of the trial in the intervention
1Department of Infectious Disease Epidemiology, London School of
Hygiene & Tropical Medicine, London, UK
2London Hub for Trials Methodology Research, MRC Clinical Trials Unit
at University College London, London, UK
3Department of Social and Environmental Health Research, London
School of Hygiene & Tropical Medicine, London, UK
Corresponding author:
Jennifer A Thompson, Department of Infectious Disease Epidemiology,
London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Email: jennifer.thompson@lshtm.ac.uk
condition. At the beginning of each period, one of the
sequences switches to the intervention, as shown in
Figure 1(a). This means that a design with k sequences
has k 2 1 periods between the first sequence switching
and the final sequence switching to the intervention
condition. We will call this section of the trial ‘rollout’
because the intervention has been introduced to some
but not all the clusters.
Before and after rollout, that is, before the first
sequence switches to the intervention and after the final
sequence switches to the intervention, there can be
additional periods of data collection that may be longer
or shorter than the periods during rollout (Figure 1(b)
and (d)). In a standard SWT design (Figure 1(a)), these
periods are the same length as the periods between roll-
out. Variations of the SWT design could include only
the rollout period (Figure 1(c)), a period before rollout
but not after or after rollout but not before.
There are many further possible variations but in this
article, we only consider designs where the same num-
ber of observations is collected in each of the periods
during rollout and that the same number of clusters is
randomised to each sequence. This implies that the roll-
out will occur at an even pace, that is, equal numbers of
clusters implement the intervention at each time, which
we feel is a natural constraint when there are limited
resources to conduct the implementation. We focus on
data with equal correlation within each cluster.1
There are several approaches to sample size calcula-
tion for SWTs;2–5 the simplest is the design effect
approach. Here, a sample size is calculated assuming
individual randomisation and is then multiplied by a
design effect to increase the sample size appropriately
for a different design. Woertman et al. developed what
they termed a design effect for an SWT, but this must
be multiplied by the number of periods in the trial to
give what we define here as the design effect.2,6 While
their design effect has been a useful contribution to the
literature, it is difficult to untangle the effects of each
design component on the sample size to examine how
to improve the efficiency of SWTs.
One such component which cannot be examined by
the design effect of Woertman et al. is the number of
periods before and after rollout; changing the number
of periods before rollout increases the total cluster size
so it is difficult to examine the impact of this change
holding the total cluster size constant.2 Girling and
Hemming found that having half a period before roll-
out and half a period after rollout produced greater
efficiency than the standard design when the total clus-
ter size was held constant,7 but it is not known whether
even fewer observations before and after rollout would
Figure 1. Diagrammatic illustrations of trial designs. Each has the same number of clusters and the same total cluster size. (a)–(d)
Stepped wedge cluster-randomised trials (SWTs) with four sequences varying the amount of data before and after rollout. (a)
Standard design: the same number of observations before and after rollout and between sequences switching, (b) number of
observations before and after rollout is half the number between sequences switching, (c) optimised design: no observations before
or after rollout, (d) no observations before rollout, 50% after rollout. (e)–(g) Other designs: (e) parallel cluster-randomised trial:
CRT, (f) parallel cluster-randomised trial with baseline observations, (g) hybrid design with 50% CRT, 50% SWTwith four sequences
and the number of observations before and after rollout equal to half the number between sequences switching.
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be more efficient. In addition, although there is a con-
sensus through empirical evidence that the power of a
standard SWT increases with an increase in the number
of sequences,2,3 this has not been explored for varia-
tions of the SWT design.
Researchers often cite increased statistical power as
a reason for choosing SWTs over other trial designs.8
Designs where clusters act as their own control can be
more powerful,7 but they also require assumptions
about changes in the outcome over time. Comparisons
have been made between SWTs and parallel cluster-
randomised trials (CRTs; Figure 1(e)), CRTs with
baseline observations where half of the total cluster size
are baseline observations (Figure 1(f)), and more
recently with the hybrid design described by Girling
and Hemming.7 The hybrid design includes sequences
that are in the control or intervention conditions for
the entire study and allows allocation to those two
sequences to differ from allocation to the remaining
sequences which form an SWT design, as shown in
Figure 1(g). Standard SWT designs have been found to
be more efficient than CRTs when the intracluster cor-
relation coefficient (ICC) is high and when the total
cluster sizes are large, and a standard SWT with four
or more sequences always has more power than a CRT
with baseline observations.6,9–11 The hybrid design
appears to have the highest power as it is most flexible,7
but the degree of efficiency gain from allowing unequal
allocation has not been established.
In this article, we give a new design effect expression
for an SWT that allows the number of observations
before and after rollout to vary without increasing the
total cluster size but maintains the requirement com-
mon to the standard SWT of equal-sized periods
between sequences switching to the intervention and the
same number of clusters randomised to each sequence.
This allowed us to identify the optimal number of
sequences and the optimal number of observations
before and after rollout to minimise the required num-
ber of clusters for a given power, ICC, and total cluster
size. We compare the efficiency of our optimised SWT
designs to several other common trial designs for a
given power, ICC, and total cluster size, and we provide
guidance in choosing a trial design. An example is then
used to demonstrate the difference in sample size
between possible designs.
Methods
SWT
Woertman et al. developed a design effect for an SWT
under the assumptions of the Hussey and Hughes anal-
ysis model.2,3,6 We rewrite this design effect based on
similar methodology to that used by Woertman et al.2
In our new design effect, the number of observations
before and after rollout is specified as proportions of
the total cluster size. For example, one could have half
of all observations after rollout and none before roll-
out, as shown in Figure 1(d).
For simplicity, we assumed that the outcome is nor-
mally distributed, clusters are of equal size, and obser-
vations are equally correlated within clusters regardless
of time or whether from the control or intervention
condition. We assume that the intervention effect is
constant over time, is fully realised by the first observa-
tion after the intervention is implemented, and is com-
mon across all clusters. We also require that secular
trends are common to all clusters, the same number of
clusters is randomised to each sequence, and that there
is the same number of observations in all periods
between sequences switching to the intervention.
This new design effect will be used to find the combi-
nation of number of sequences and proportion of
observations before and after rollout that minimise the
sample size (number of clusters) for a given power,
total cluster size, and ICC. This SWT, derived under
the constraint of equal allocation to sequences, will be
referred to as an ‘optimised’ SWT.
This optimised SWT will then be compared to other
trial designs. We will consider a CRT, a CRT with base-
line observations and the hybrid design.7 Throughout
these comparisons, we fix the power, total cluster size,
and ICC.
Parallel CRT
A CRT (Figure 1(e)) is an attractive design because the
intervention effect is not confounded with time and so
it does not require assumptions about secular trends.
The published design effect for a CRT is as follows
DECRT = 1+ m 1ð Þr ð1Þ
where m is the total cluster size, and r is the ICC.12
Parallel CRT with baseline observations
A CRT with baseline observations (Figure 1(f)) is
equivalent to an SWT with two sequences, some pro-
portion of observations before rollout and no observa-
tions after rollout.13 Making the same assumptions as
the SWT, such a design can be analysed with the same
model as an SWT,3 and so, the new design effect can
also be applied. We used our design effect to find the
optimum proportion of observations to have at base-
line to minimise the sample size of this design before
comparing the required sample size to the optimised
SWT.
Hybrid design trial
Girling and Hemming described a trial design where
some of the clusters were randomised to a parallel
Thompson et al. 641
CRT, while the remaining clusters were randomised to
an SWT with half a period before rollout and half a
period after rollout (Figure 1(g)).7 This hybrid trial
design makes the same assumptions as the SWT and
can be analysed with the Hussey and Hughes analysis
model.3 They found that the optimal proportion of
clusters to randomise to the SWT was the cluster-mean
correlation defined as follows7
R=
mr
1+ m 1ð Þr
where 0R 1 increases as the ICC or total cluster size
increases. So, when the ICC or cluster size increases,
the optimal proportion of clusters randomised to the
SWT increases and the proportion randomised to the
CRT reduces.
The hybrid design is flexible enough that it can sim-
plify to a parallel CRT, it can simplify to a design simi-
lar to a standard SWT but with half a period before
and half a period after rollout (Figure 1(b)), and it can
simplify to a modified SWT design with no period
before and after rollout, and the first and final periods
are half the size of the other periods, similar to the
design considered later in this article. The first two of
these simplifications are straightforward to see; all clus-
ters are randomised to the relevant part of the trial.
The final simplification requires a proportion of 2/(k
+ 2) clusters to be randomised to the parallel CRT
and the remaining clusters to be randomised to the
SWT with k sequences. Following the recommenda-
tions of Girling and Hemming will lead to one of these
designs if it is the most efficient option or it will lead to
a hybrid design if that is most efficient.7
We compared our optimised SWT with k sequences
to an optimal hybrid design to see whether the
increased flexibility of the hybrid design gave a practi-
cally relevant decrease in sample size. The optimal
hybrid had a proportion equal to the cluster-mean cor-
relation of clusters randomised to the SWT, and the
SWT within the hybrid had as many sequences as there
were clusters.
Choosing an SWT design
Finally, we acknowledge that the optimised SWT may
not always be a practical design and provide recom-
mendations for how to design an efficient and practical
trial. We provide an example to demonstrate the differ-
ences in sample size of different designs.
Results
The design effect for an SWT
We define k as the number of sequences, b as the pro-
portion of the total cluster size that is before rollout,
and a the proportion of the total cluster size that is
after rollout. For example, in a standard SWT,
b=a= 1=(k+ 1) (Figure 1(a)), alternatively one
could have no observations before rollout, so b= 0,
but a large period after rollout, say half of the total
cluster size, so a= 0:5 (Figure 1(d)). The total cluster
size remains the same regardless of a and b, and the
remaining observations are distributed equally between
the periods within rollout.
In Appendix 1, we derive a design effect for an SWT
with these characteristics
DESWT = 1+ m 1ð Þrð Þ 3k k  1ð Þ
2 k+ 1ð Þ
1 Rð Þ
1 b+að Þ½  k 1 0:5R 1 b+að Þ½ ð Þ  1½ 
ð2Þ
The terms a and b only affect the design effect
through their sum a+b and so it is the combined pro-
portion of observations outside rollout that affects the
power, rather than the individual quantities. a and b
are also exchangeable in this equation; this means that
observations before and after rollout have the same
impact on power. This is due to the assumption of
observations being equally correlated within each
cluster.
Minimising the sample size of an SWT
In Appendix 2, we show that the optimised SWT has
no observations outside rollout (a+b= 0; Figure
1(c)) with the number of sequences depending on the
ICC and total cluster size, as shown in equation (3)
Optimal number of sequences=
1
1 ﬃﬃﬃRp ð3Þ
Equation (3) will give a non-integer number; to find
the exact optimal number of sequences, calculate the
design effect (equation (2)) for the integers either side
of the result given by equation (3), but a rule of thumb
is to round the result to the nearest integer.
The optimal number of sequences increases as the
cluster-mean correlation increases (i.e. the ICC or total
cluster size increase), but for low cluster-mean correla-
tion (low ICC or small total cluster size), a small num-
ber of sequences is optimal. For example, with 100
observations per cluster and an ICC = 0.01
(R = 0.50), it is optimal to have 3 sequences, but with
an ICC = 0.1 (R = 0.92), it is optimal to have 24
sequences. Figure 2 shows the optimal number of
sequences for different cluster-mean correlations.
Minimising the sample size of a CRT with baseline
observations
The design effect (equation (2)) can also give the opti-
mal proportion of baseline observations for a CRT. In
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Appendix 4, we show that the proportion of observa-
tions at baseline that minimises the sample size of a
CRT with baseline observations is as follows
b=
1 1
2R
if R  1
2
0 otherwise
8<
: ð4Þ
For low values of the cluster-mean correlation, it is
optimal to have no baseline observations, and for
higher values, the optimal proportion of baseline mea-
surements increases to a ceiling of 50% of observations.
Comparison of an optimised SWT to a CRT
In Appendix 3, we show that when the optimal number
of sequences from equation (3) is\2.5, this means that
a CRT would require a smaller sample size than any
SWT with no observations outside rollout. As a rule of
thumb, a CRT will require a smaller sample size when
r\
1
9
16
m+ 1
For example, with 100 observations per cluster, a
CRT will require fewer clusters than an SWT with no
observations outside rollout if ICC \ 0.005.
Alternatively, a CRT can be compared to a specific
SWT with k sequences and no observations outside roll-
out. The CRT will require a smaller sample size when
r\
1
k+ 1ð Þ
k  1ð Þ m+ 1
In Appendix 5, we show that a CRT with baseline
observations will always require the same or a larger
sample size than the optimised SWT.
Comparison to a hybrid design
Figure 3 shows the relative sample size of the SWT
with no observations outside rollout and 3, 4, 5, or 20
sequences compared to the optimised hybrid design.
The optimal SWT, with the optimal number of
sequences, is the lowest line at any value of R. For
example, at R = 0.2, two sequences are optimal, but at
R = 0.7, five sequences are optimal. While the hybrid
always has the smaller sample size of the two designs,
the differences are small when compared to the optimal
SWT, and the optimal SWT requires at most a 5%
larger sample size than the hybrid design.
Other pragmatic SWT designs: a non-optimal
number of sequences and including observations
outside rollout
It may not always be practical to use the optimal num-
ber of sequences calculated in equation (3) as this may
be a large number. The primary constraint on the num-
ber of sequences is that it cannot exceed the number of
clusters in the trial, and the number of periods in the
trial cannot exceed the total cluster size. Furthermore,
in many settings, the logistical effort to implement the
Figure 3. Graph of the sample size of the SWTwith no
observations outside rollout, relative to the optimised hybrid
against the cluster-mean correlation. Darkest and dotted
line = 2 sequences, lightest and solid line = 20 sequences. The
optimal SWT is the lowest line at any given cluster-mean
correlation.
Figure 2. Optimal number of sequences by the cluster-mean
correlation. The number of sequences tends to infinity as the
cluster-mean correlation tends to 1.
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intervention at many different time points would be too
great.
In such cases, a smaller, feasible number of sequences
could be selected and there may then be some gain from
obtaining observations outside rollout. For a fixed num-
ber of sequences, the optimal proportion of observations
outside rollout (see Appendix 2 for derivation) is a func-
tion of the number of sequences and the cluster-mean
correlation, as shown in equation (5)
a+b=
1 k  1ð Þ
k
1
R
if R  k  1ð Þ
k
0 otherwise
8<
: ð5Þ
For low values of the cluster-mean correlation, that
is, low ICC or small total cluster size, it is optimal to
have no observations outside rollout, and for higher
values, as the ICC or total cluster size increases, the
optimal proportion outside rollout increases up to a
proportion of 1/k.
This proportion varies between 0 (no observations
outside rollout) and 1/k (equivalent to the same num-
ber of observations outside rollout as in one period of
the trial). This tells us that the standard SWT, with 1/k
observations before and 1/k observations after rollout,
is inefficient.
For an SWT with the proportion of observations
outside rollout selected from equation (5), increasing
the number of sequences reduces the sample size of the
design (see Appendix 7). However, there is little gain
from increasing past five sequences, after which there is
a maximum 4% further reduction in the sample size.
This is only true while R  (k  1)=k, equivalent to
k\1=(1 R). When the number of sequences passes
this threshold, the sample size is smallest with no obser-
vations outside rollout and increasing the number of
sequences will only continue to reduce the sample size
up to the optimal number of sequences from equation
(3). Appendix 7 contains comparisons of an SWT with
this proportion of the observations outside rollout to
the other trial designs considered in this article.
Selecting an SWT design
One strategy for selecting an SWT design with an equal
number of clusters in each sequence and an equal num-
ber of observations in each period is as follows:
1. Calculate the optimal number of sequences using
equation (3).
2. If the number of sequences is feasible, then you
have the optimal SWT design by selecting this
number of sequences and collecting no observa-
tions outside of rollout.
3. If the number of sequences is unfeasibly high, select
the number closest to this value that is feasible.
Then, compare the cluster-mean correlation to the
chosen number of sequences using equation (5) to
see whether there is any gain from including obser-
vations outside rollout.
Several iterations of designs may be needed to
achieve an equal number of clusters in each sequence,
varying the numbers of clusters or sequences, so the
former is a multiple of the latter. Iterations may also be
required to achieve an equal number of observations in
each period, varying the total cluster size and number
of periods, so the former is a multiple of the latter.
Alternatively, the Stata command by Hemming et al.
can be used to calculate the power of an unbalanced
design.4 Once the most appropriate SWT design has
been identified, the sample size can be compared with
other potential designs such as the CRT and hybrid
design if these are feasible.
Example
Consider a CRT designed to yield 80% power to detect
a mean difference of 0.1 in a continuous outcome with
a total variance of 1, using a two-sided test at the 5%
significance level. The ICC is 0.04, and the total num-
ber of observations per cluster is 84. Table 1 shows the
number of clusters required to achieve 80% power by
several designs. For each design, we give the number of
clusters given by the relevant design effect and the num-
ber of clusters and power after allowing for an equal
number of clusters allocated to each sequence. For the
power of some designs, we also made small changes to
the total cluster size so that there are an equal number
of observations in each period of the trial.
The optimised SWT has eight sequences (and no
observations outside rollout). After adjusting the num-
ber of clusters to get the same number in each sequence,
this design required 88 clusters. Increasing the number
of sequences to 88 (one cluster randomised to each
sequence) resulted in the design effect giving a larger
required number of clusters; this design is an impracti-
cal design only given to show that the required number
of clusters does not decrease with more sequences.
Other SWT designs required between 96 and 99 clusters
to achieve 80% power.
A CRT requires almost twice as many clusters as the
optimised SWT (162 clusters), and a CRT with baseline
observations requires 112 clusters. As expected, the
optimised hybrid design, with 78% of clusters rando-
mised to an SWT with 17 sequences, required slightly
fewer clusters than the optimised SWT.
Discussion
We have shown that the sample size of an SWT under
equal allocation to sequences can be minimised by col-
lecting all observations within rollout. Unlike the stan-
dard SWT, in this optimised SWT, the optimal number
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of sequences depends on the cluster-mean correlation.
We have also provided advice on when to consider
other trial designs, acknowledging that a hybrid design
will be always slightly more efficient.
Our finding that the most efficient SWT design is to
have no observations outside rollout, at least if the
resulting optimal number of sequences is also feasible,
has not been suggested previously. This optimised
SWT may, however, be unacceptable because not all
the clusters will receive the intervention during the trial.
Trialists may want to include some observations after
rollout to avoid a ‘disappointment effect’ in the clusters
that would not otherwise receive the intervention.
Alternatively, the intervention could still be implemen-
ted after data collection has been completed.
We found that there were an optimal number of
sequences for minimising the sample size of the SWT
with no observations outside rollout. The number was
large when the cluster-mean correlation was high (high
ICC or large total cluster size) but small when the
cluster-mean correlation was low (small ICC and small
total cluster size). This contrasts with previous research
for the standard SWT which showed that the sample
size reduced as the number of sequences increased.2,3 It
is, however, consistent with the consensus in the litera-
ture and finding of this study that a CRT requires a
smaller sample size than an SWT when the ICC and
total cluster size are low.7,10
We examined the optimal proportion of baseline
observations in a CRT. We found that when the
cluster-mean correlation is low, there is no benefit for
the power of the study from including baseline observa-
tions. This is because when the ICC is high, the baseline
observations will explain more of the variability in the
follow-up measurements than when the ICC is low.
Our results differed to much of the current literature
that suggests that there is always a benefit to including
baseline measurements.14,15 In this literature, total clus-
ter size was not held constant – instead, baseline obser-
vations were included as additional observations
relative to a design with no baseline.
This article is the first to compare the sample size
implications of increasing the proportion of observa-
tions outside rollout versus increasing the number of
sequences. We have found that increasing the number
of sequences can have a larger impact on the sample
size than increasing the proportion of observations out-
side rollout. For example, there is a larger reduction in
sample size (providing the ICC and total cluster size
are large enough) going from a CRT to an SWT with
three sequences and no observations outside rollout
than adding baseline observations to a CRT.
We found that the optimal number of sequences
quickly increased with the ICC and total cluster size to
a number that may not be practical. In cases such as
this where a non-optimal number of sequences is cho-
sen, we found that observations outside rollout may
compensate and provide a reduction in the sample size;
however, it is never beneficial to the sample size to have
more observations outside rollout than are collected in
Table 1. Illustrative example of the number of clusters required by different designs to achieve 80% power to detect a difference of
0.1 with standard deviation of 1.
Design Calculated
number of clusters
Final design
Number of clusters
after rounding
Total cluster
sizea
Power (%)
Optimised SWT
8 sequences, no observations outside rollout 86.1 88 84 81
Other SWT designs
88 sequences, no observations outside rollout 87.7 88 87 81
8 sequences, 22% outside rollout (standard SWT) 94.0 96 81 80
3 sequences, no observations outside rollout 96.9 99 84 81
3 sequences, optimal outside rollout (14%) 94.2 96 84 81
Other designs
CRT 161.5 162 84 80
CRTwith optimal proportion of
observations at baseline (36%)
111.6 112 84 80
Hybrid: 78% 17-sequence SWTs (optimalb) 84.8 86: 68 SWTs, 18 CRTs 85 81
CRT: parallel cluster-randomised trial; SWT: stepped wedge trial.
Total cluster size = 84, intracluster correlation coefficient (ICC) = 0.04, 5% significance level and 80% power.
Difference in calculated number of clusters and final number of clusters is due to rounding up and the requirement for an equal number of clusters
per sequence.
aFor power calculations, the total cluster size had to be varied for some of these designs to allow an equal number of observations in each period of
the trial.
bThe optimal number of sequences was 68, which gave a calculated number of clusters or 84.7. For 17 sequences, the calculated number is higher,
but the final number of clusters required was the same as for 68 sequences and allowed a total cluster size similar to the other designs being
considered.
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one period of the trial, similar to the results from
Girling and Hemming.7
Some recently published SWTs included a large pro-
portion of data outside of rollout, usually with the jus-
tification of investigating the longer-term effect of the
intervention.1,16 These designs will give a larger var-
iance for the intervention effect than our optimised
SWT design with the same number of observations
would have done. Trialists should also be aware that
with no control observations after rollout, it will be dif-
ficult to assess whether changes in the outcome are due
to changes in the intervention effect or other reasons.
Our design effect assumes that the intervention effect
remains constant throughout the trial. If this is not
expected to be the case, different methods of sample
size calculation, such as simulations,5 and more com-
plex analysis methods should be used.
We found that the hybrid design was more efficient
than the optimised SWT, as expected, due to its addi-
tional flexibility to allow unequal allocation to
sequences. However, the gain in efficiency from this
flexibility was at most 5%. Therefore, where consider-
able additional resources would be required to imple-
ment the intervention in a larger number of clusters at
the start of the trial than at subsequent switches, the
hybrid design will be unattractive. This might be the
case if, for example, there is only one team available to
roll the intervention out. The optimised hybrid design
does not, however, always allocate more clusters to
implement the intervention immediately than to other
sequences, so one approach to design is to first see
whether the optimised hybrid is feasible, and if not,
then consider the optimised SWT under equal
allocation.
We have given comparisons to some alternative
designs, but there are many designs that we have not
included. We have not explored incomplete designs
such as the dog-leg design or unbalanced SWTs.17,18
We have compared trial designs fixing the total cluster
size, but a further area of research could vary the total
cluster size and fix the number of clusters or look to
minimise a combination of the two. In some settings,
there may be little or no cost associated with collecting
observations before or after rollout, for example, with
routinely collected data. If this is the case, it may be
more informative to compare trial designs for a given
cost rather than a fixed total cluster size.
As with all design effects, the assumptions made
about the data must hold for the design effect to be
valid, such as exchangeability within clusters and time
trends that are common to all clusters. If these assump-
tions do not hold, using the design effect given here
may result in an underpowered trial as the assumed
analysis model would be inappropriate. These assump-
tions have sometimes been criticised as being unrealis-
tic, and others have provided design effects where some
assumptions have been relaxed.19–21 Baio et al. found
the assumption of normality affected sample size calcu-
lations for binary outcomes.5
Power is only one consideration of many when
selecting a trial design. Caution should also be used in
designing trials with very few clusters; among other
issues, this may reduce generalisability and increase the
possibility of chance imbalances.22 The lower sample
size requirements of SWT and hybrid designs com-
pared to a CRT come at the cost of requiring assump-
tions about how the outcome is changing over time
because the intervention effect is confounded with time.
Care needs to be taken to ensure that these assump-
tions are appropriate and that the analysis takes this
into account adequately.19
We have identified SWT designs that require fewer
clusters than the standard SWT and facilitated compar-
isons of statistical power between competing trial
designs. Following our guidance on selecting a design
will result in more efficient trials.
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